Laboratory Of America Holdings Net Income 2006-2018 | LH

Laboratory Of America Holdings annual/quarterly net income history and growth rate from 2006 to 2018. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Laboratory Of America Holdings net income for the quarter ending December 31, 2018 was $0.158B, a 77.04% decline year-over-year.
  • Laboratory Of America Holdings net income for the twelve months ending December 31, 2018 was $0.884B, a 27.98% decline year-over-year.
  • Laboratory Of America Holdings annual net income for 2018 was $0.884B, a 27.98% decline from 2017.
  • Laboratory Of America Holdings annual net income for 2017 was $1.227B, a 72.39% increase from 2016.
  • Laboratory Of America Holdings annual net income for 2016 was $0.712B, a 62.66% increase from 2015.
Laboratory Of America Holdings Annual Net Income
(Millions of US $)
2018 $884
2017 $1,227
2016 $712
2015 $438
2014 $511
2013 $574
2012 $583
2011 $520
2010 $558
2009 $543
2008 $465
2007 $477
2006 $432
2005 $386
Laboratory Of America Holdings Quarterly Net Income
(Millions of US $)
Q4 2018 $158
Q3 2018 $319
Q2 2018 $234
Q1 2018 $173
Q4 2017 $688
Q3 2017 $172
Q2 2017 $185
Q1 2017 $183
Q4 2016 $164
Q3 2016 $180
Q2 2016 $204
Q1 2016 $164
Q4 2015 $110
Q3 2015 $155
Q2 2015 $170
Q1 2015 $3
Q4 2014 $120
Q3 2014 $137
Q2 2014 $141
Q1 2014 $113
Q4 2013 $126
Q3 2013 $148
Q2 2013 $152
Q1 2013 $147
Q4 2012 $120
Q3 2012 $148
Q2 2012 $153
Q1 2012 $162
Q4 2011 $135
Q3 2011 $134
Q2 2011 $123
Q1 2011 $127
Q4 2010 $132
Q3 2010 $140
Q2 2010 $154
Q1 2010 $133
Q4 2009 $143
Q3 2009 $131
Q2 2009 $136
Q1 2009 $133
Q4 2008 $118
Q3 2008 $112
Q2 2008 $104
Q1 2008 $130
Q4 2007 $114
Q3 2007 $111
Q2 2007 $129
Q1 2007 $123
Q4 2006 $104
Q3 2006 $110
Q2 2006 $116
Q1 2006 $102
Q4 2005 $89
Q3 2005 $95
Q2 2005 $106
Q1 2005 $97
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $14.330B $11.333B
Laboratory Corporation of America Holdings is a leading global life sciences company that is deeply integrated in guiding patient care, providing comprehensive clinical laboratory and end-to-end drug development services. With a mission to improve health and improve lives, LabCorp delivers world-class diagnostic solutions, brings innovative medicines to patients faster and uses technology to improve the delivery of care.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $61.317B 20.37
Align Technology (ALGN) United States $22.518B 57.33
McKesson (MCK) United States $21.887B 8.52
AmerisourceBergen (ABC) United States $15.293B 11.09
Cooper (COO) United States $13.885B 24.22
Cardinal Health (CAH) United States $13.709B 9.24
DENTSPLY SIRONA (XRAY) United States $11.127B 24.74
Henry Schein (HSIC) United States $9.192B 14.86
West Pharmaceutical Services (WST) United States $8.223B 39.69
Merit Medical Systems (MMSI) United States $3.170B 34.12
CONMED (CNMD) United States $2.242B 36.43
Patterson (PDCO) United States $2.031B 16.05
Atrion (ATRI) United States $1.612B 47.31
STAAR Surgical (STAA) United States $1.380B 115.59
Antares Pharma (ATRS) United States $0.437B 0.00
Invacare (IVC) United States $0.222B 0.00
Lifevantage (LFVN) United States $0.158B 21.27
Pro-Dex (PDEX) United States $0.063B 28.64
Endologix (ELGX) United States $0.060B 0.00
Biolase (BIOL) United States $0.049B 0.00